MVP 1.03% 48.0¢ medical developments international limited

Unfortunately, MVP is a one trick pony. The respiratory products...

  1. 354 Posts.
    lightbulb Created with Sketch. 1
    Unfortunately, MVP is a one trick pony. The respiratory products do not produce enough revenue and are unlikely to grow significantly. Lot's of growth to come from Penthrox but that leaves MVP open to risk from competitors.
 
watchlist Created with Sketch. Add MVP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.